Amor De Madre Adult Care Home LLC

Based on documentation review and interview, the manager failed to ensure that an employee provided documentation of freedom from infectious tuberculosis (TB) on or before the date the individual began providing services at or on behalf of the assisted living facility and as specified in R9-10-113, for two of two employees sampled. Findings include: 1. R9-10-113.A states "If a health care institution is subject to the requirements of this Section, as specified in an Article in this Chapter, the health care institution's chief administrative officer shall ensure that the health care institution establishes, documents, and implements tuberculosis infection control activities that: 2. Include: c. Annually providing training and education related to recognizing signs and symptoms of tuberculosis to individuals employed by or providing volunteer services for the health care institution.” 2. A review of E1's and E2's personnel records revealed no documentation of annual TB training for 2025. E1's last documented TB training was dated January 19, 2024, and E2’s last documented TB training was dated August 14, 2024. 3. In an exit interview, the findings were reviewed with E1 and no further information was provided.

Based on record review and interview, the manager failed to ensure a medication administered to a resident was documented in the resident's medical record, for one of two residents sampled who received medication administration. Findings include: 1. A review of R2's medical record revealed a service plan, dated September 2, 2024, for personal care services including medication administration. 2. A review of R2's medical record revealed an order, dated August 30, 2024, for, "Gabapentin 100 mg capsule, take 1 capsule by oral route at bedtime." 3. A review of R2's medical record revealed an Medication Administration Record (MAR) dated October 2024. The MAR documented the medications administered to R2 during the month of October, 2024. However, the MAR did not document the administration of Gabapentin 100 milligram capsules to R2. 4. In an interview, E1 acknowledged the MAR provided for R2 did not accurately document the medications administered to R2.